152 related articles for article (PubMed ID: 30159860)
1. Molecular profiling of different glioma specimens from an Ollier disease patient suggests a multifocal disease process in the setting of IDH mosaicism.
Tan CL; Vellayappan B; Wu B; Yeo TT; McLendon RE
Brain Tumor Pathol; 2018 Oct; 35(4):202-208. PubMed ID: 30159860
[TBL] [Abstract][Full Text] [Related]
2. Supratentorial multifocal gliomas associated with Ollier disease harboring IDH1 R132H mutation: A case report.
Ikeda H; Yamaguchi S; Ishi Y; Wakabayashi K; Shimizu A; Kanno-Okada H; Endo T; Ota M; Okamoto M; Motegi H; Iwasaki N; Fujimura M
Neuropathology; 2023 Oct; 43(5):413-420. PubMed ID: 36942363
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of gliomas in patients with somatic IDH mosaicism.
Bonnet C; Thomas L; Psimaras D; Bielle F; Vauléon E; Loiseau H; Cartalat-Carel S; Meyronet D; Dehais C; Honnorat J; Sanson M; Ducray F
Acta Neuropathol Commun; 2016 Mar; 4():31. PubMed ID: 27036230
[TBL] [Abstract][Full Text] [Related]
4. Enchondromatosis-associated oligodendroglioma: case report and literature review.
Achiha T; Arita H; Kagawa N; Murase T; Ikeda JI; Morii E; Kanemura Y; Fujimoto Y; Kishima H
Brain Tumor Pathol; 2018 Jan; 35(1):36-40. PubMed ID: 29224049
[TBL] [Abstract][Full Text] [Related]
5. Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.
Kawaguchi T; Sonoda Y; Shibahara I; Saito R; Kanamori M; Kumabe T; Tominaga T
J Neurooncol; 2016 Sep; 129(3):505-514. PubMed ID: 27401154
[TBL] [Abstract][Full Text] [Related]
6. The Histopathologic and Radiologic Features of T2-FLAIR Mismatch Sign in IDH-Mutant 1p/19q Non-codeleted Astrocytomas.
Fujita Y; Nagashima H; Tanaka K; Hashiguchi M; Hirose T; Itoh T; Sasayama T
World Neurosurg; 2021 May; 149():e253-e260. PubMed ID: 33610870
[TBL] [Abstract][Full Text] [Related]
7. A Rare Co-Occurrence of Maffucci Syndrome and Astrocytoma with IDH1 R132H Mutation: A Case Report.
Ashirov N; Mammadinova I; Moldabekov A; Zhetpisbaev B; Teltayev D; Ryskeldiyev N; Akshulakov S
Medicina (Kaunas); 2023 May; 59(6):. PubMed ID: 37374260
[No Abstract] [Full Text] [Related]
8. IDH1 immunohistochemistry reactivity and mosaic IDH1 or IDH2 somatic mutations in pediatric sporadic enchondroma and enchondromatosis.
Saiji E; Pause FG; Lascombes P; Cerato Biderbost C; Marq NL; Berczy M; Merlini L; Rougemont AL
Virchows Arch; 2019 Nov; 475(5):625-636. PubMed ID: 31240473
[TBL] [Abstract][Full Text] [Related]
9. Radio-chemotherapy improves survival in IDH-mutant, 1p/19q non-codeleted secondary high-grade astrocytoma patients.
Juratli TA; Lautenschläger T; Geiger KD; Pinzer T; Krause M; Schackert G; Krex D
J Neurooncol; 2015 Sep; 124(2):197-205. PubMed ID: 26033545
[TBL] [Abstract][Full Text] [Related]
10. Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome.
Pansuriya TC; van Eijk R; d'Adamo P; van Ruler MA; Kuijjer ML; Oosting J; Cleton-Jansen AM; van Oosterwijk JG; Verbeke SL; Meijer D; van Wezel T; Nord KH; Sangiorgi L; Toker B; Liegl-Atzwanger B; San-Julian M; Sciot R; Limaye N; Kindblom LG; Daugaard S; Godfraind C; Boon LM; Vikkula M; Kurek KC; Szuhai K; French PJ; Bovée JV
Nat Genet; 2011 Nov; 43(12):1256-61. PubMed ID: 22057234
[TBL] [Abstract][Full Text] [Related]
11. Multifocal supratentorial diffuse glioma in a young patient with Ollier disease.
Pearce P; Robertson T; Ortiz-Gomez JD; Rajah T; Tollesson G
J Clin Neurosci; 2012 Mar; 19(3):477-8. PubMed ID: 22249016
[TBL] [Abstract][Full Text] [Related]
12. Brain and skull base MRI findings in patients with Ollier-Maffucci disease: A series of 12 patient-cases.
Mandonnet E; Anract P; Martin E; Roujeau T; Spena G; Cormier-Daire V; Duffau H; Baujat G;
Clin Neurol Neurosurg; 2017 Sep; 160():147-151. PubMed ID: 28750360
[TBL] [Abstract][Full Text] [Related]
13. Impending Impact of Molecular Pathology on Classifying Adult Diffuse Gliomas.
Macaulay RJ
Cancer Control; 2015 Apr; 22(2):200-5. PubMed ID: 26068765
[TBL] [Abstract][Full Text] [Related]
14. Maffucci syndrome complicated by three different central nervous system tumors sharing an IDH1 R132C mutation: case report.
Nejo T; Tanaka S; Ikemura M; Nomura M; Takayanagi S; Shin M; Ushiku T; Shibahara J; Saito N; Mukasa A
J Neurosurg; 2018 Dec; 131(6):1829-1834. PubMed ID: 30579273
[TBL] [Abstract][Full Text] [Related]
15. Somatic mosaic mutations of IDH1 and NPM1 associated with cup-like acute myeloid leukemia in a patient with Maffucci syndrome.
Akiyama M; Yamaoka M; Mikami-Terao Y; Ohyama W; Yokoi K; Arakawa Y; Takita J; Suzuki H; Yamada H
Int J Hematol; 2015 Dec; 102(6):723-8. PubMed ID: 26508204
[TBL] [Abstract][Full Text] [Related]
16. A Case of Ollier's Disease with P53 Mutation Positive and IDH1 (R132H) Negative Multicentric Gliomas.
Nishtha Y; Maya B; Shetty SS; Ganaraj VH; Nupur P; Yasha TC; Netravathi M
Neurol India; 2020; 68(3):657-659. PubMed ID: 32643682
[TBL] [Abstract][Full Text] [Related]
17. Somatic IDH1 mutation in a pituitary adenoma of a patient with Maffucci syndrome.
Hao S; Hong CS; Feng J; Yang C; Chittiboina P; Zhang J; Zhuang Z
J Neurosurg; 2016 Jun; 124(6):1562-7. PubMed ID: 26473790
[TBL] [Abstract][Full Text] [Related]
18. MR imaging phenotype correlates with extent of genome-wide copy number abundance in IDH mutant gliomas.
Wu CC; Jain R; Neto L; Patel S; Poisson LM; Serrano J; Ng V; Patel SH; Placantonakis DG; Zagzag D; Golfinos J; Chi AS; Snuderl M
Neuroradiology; 2019 Sep; 61(9):1023-1031. PubMed ID: 31134296
[TBL] [Abstract][Full Text] [Related]
19. Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2.
Amary MF; Damato S; Halai D; Eskandarpour M; Berisha F; Bonar F; McCarthy S; Fantin VR; Straley KS; Lobo S; Aston W; Green CL; Gale RE; Tirabosco R; Futreal A; Campbell P; Presneau N; Flanagan AM
Nat Genet; 2011 Nov; 43(12):1262-5. PubMed ID: 22057236
[TBL] [Abstract][Full Text] [Related]
20. IDH2 and TP53 mutations are correlated with gliomagenesis in a patient with Maffucci syndrome.
Moriya K; Kaneko MK; Liu X; Hosaka M; Fujishima F; Sakuma J; Ogasawara S; Watanabe M; Sasahara Y; Kure S; Kato Y
Cancer Sci; 2014 Mar; 105(3):359-62. PubMed ID: 24344754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
